tradingkey.logo

Twist Bioscience Corp

TWST
查看詳細走勢圖
33.050USD
-0.530-1.58%
收盤 12/26, 16:00美東報價延遲15分鐘
2.00B總市值
虧損本益比TTM

Twist Bioscience Corp

33.050
-0.530-1.58%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-1.58%

5天

+1.66%

1月

+4.26%

6月

-10.53%

今年開始到現在

-28.88%

1年

-32.86%

查看詳細走勢圖

TradingKey Twist Bioscience Corp股票評分

單位: USD 更新時間: 2025-12-26

操作建議

Twist Bioscience Corp當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在藥品行業排名18/158位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價38.52。中期看,股價處於上升通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Twist Bioscience Corp評分

相關信息

行業排名
18 / 158
全市場排名
63 / 4563
所屬行業
藥品

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 11 分析師
買入
評級
38.517
目標均價
+19.54%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Twist Bioscience Corp亮點

亮點風險
Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.
業績高增長
公司營業收入穩步增長,連續3年增長53.63%
估值低估
公司最新PE估值-25.45,處於3年歷史低位
機構加倉
最新機構持股71.88M股,環比增加1.04%
景順投資公司持倉
明星投資者景順投資公司持倉,最新持倉44.76K股
活躍度增加
近期活躍度增加,過去20天平均換手率0.78

Twist Bioscience Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Twist Bioscience Corp簡介

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.
公司代碼TWST
公司Twist Bioscience Corp
CEOLeproust (Emily M)
網址https://www.twistbioscience.com/

常見問題

Twist Bioscience Corp(TWST)的當前股價是多少?

Twist Bioscience Corp(TWST)的當前股價是 33.050。

Twist Bioscience Corp 的股票代碼是什麼?

Twist Bioscience Corp的股票代碼是TWST。

Twist Bioscience Corp股票的52週最高點是多少?

Twist Bioscience Corp股票的52週最高點是55.333。

Twist Bioscience Corp股票的52週最低點是多少?

Twist Bioscience Corp股票的52週最低點是23.300。

Twist Bioscience Corp的市值是多少?

Twist Bioscience Corp的市值是2.00B。

Twist Bioscience Corp的淨利潤是多少?

Twist Bioscience Corp的淨利潤為-77.67M。

現在Twist Bioscience Corp(TWST)的股票是買入、持有還是賣出?

根據分析師評級,Twist Bioscience Corp(TWST)的總體評級為買入,目標價格為38.517。

Twist Bioscience Corp(TWST)股票的每股收益(EPS TTM)是多少

Twist Bioscience Corp(TWST)股票的每股收益(EPS TTM)是-1.299。
KeyAI